Mark J. Tarr is the CEO of Encompass Health Corporation, a role he has held since the end of 2016. He has been with the company for over 23 years, climbing the ranks from various leadership positions, showcasing his deep...

Current Market Cap

$9.98B

Number of Employees

27.21K

Total Compensation

2018 - 2023

Trending up by 285.20% last year
Showing total compensation for the last 2018 - 2023

Stock

Up by 0.00% last year

Salary

Up by 0.00% last year

Bonus

Up by 0.00% last year

Other

Down by -27.34% last year

Year

2023

Total Compensation

$4.40M

Salary

$1.05M

Board Justification

The compensation philosophy is designed to align executive compensation with performance metrics and shareholder interests, focusing on long-term value creation.

Bonus

$0.00

Board Justification

No bonus was awarded for 2023 as the focus was on long-term incentives and performance-based compensation.

Other

$66.92K

Board Justification

Other compensation includes contributions to the nonqualified 401(k) plan and other benefits.

Restricted Stock

$3.28M(54.56K RSU)

Board Justification

The stock awards that vested in 2023 were based on performance metrics achieved during the 2021-2022 performance period, with a total of 54,561 shares vesting in 2023.

Performance Metrics

The performance metrics for determining compensation include Adjusted EBITDA and quality metrics related to patient care and employee turnover.

SEC Filing

From April 2, 2024

Mark J. Tarr

CEO of Encompass Health Corporation

E

Education

Bachelor's degree from Ball State University

Field of Expertise

Healthcare & Life Sciences - Healthcare

Born

December 29, 1961 - 62 years ago

Is Founder?

No

Current Tenure

7 years 10 months (Dec 2016 - Present)

Previous Experience

Executive Vice President and Chief Operating Officer at Encompass Health

View Holdings

Insider Holdings of Mark J. Tarr

EHC

$56.54M

$24.76M (77.92%)

Last Insider Trade

EHC

$3.75M

EHC at $83.27/share

Apr 30, 2024

Sale